Yesterday, I told you about some impressive new research on a few “old standby” antioxidant supplements. Today, I want to take a minute to tell you about some recent developments with another old standby–fish oil.
A few weeks ago, the FDA approved a synthetic, patented (of course) EPA-only supplement called Vascepta for the treatment of hypertriglyceridemia. (Or, in plain English, high triglycerides.) According to the manufacturer, this new medication consists of “not less than 96% EPA.”
But what I’d like to know is: 1.) What’s the other 4 percent? And 2.) What’s wrong with regular–NATURAL–fish oil? Which contains both EPA and the equally important essential fatty acid DHA.
My point here is that there is a simple, natural, inexpensive, non-prescription way to lower your triglycerides. Which really is the most important part of the cholesterol profile–and the risk factor you should be most concerned with lowering if it’s elevated.
Yet, the establishment still thinks fish oil is “snake” oil. This is the second fish oil product to be bastardized so it can be sold as a prescription medication. It seems to me that unless they’re making money from it, then, according to them, it “probably doesn’t do much.”